MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12885-019-6275-z

Медицинская библиотека · BMC cancer · 2019

Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial.

Lende Tone Hoel, Austdal Marie, Varhaugvik Anne Elin, Skaland Ivar, Gudlaugsson Einar, Kvaløy Jan Terje, Akslen Lars A, Søiland Håvard, Janssen Emiel A M, Baak Jan P A

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Conflicting results have been reported on the influence of carbohydrates in breast cancer.

OBJECTIVE

To determine the influence of pre-operative per-oral carbohydrate load on proliferation in breast tumors.

DESIGN

Randomized controlled trial.

SETTING

University hospital with primary and secondary care functions in South-West Norway.

PATIENTS: Sixty-one patients with operable breast cancer from a population-based cohort.

INTERVENTION: Per-oral carbohydrate load (preOp™) 18 and 2-4 h before surgery (n = 26) or standard pre-operative fasting with free consumption of tap water (n = 35).

MEASUREMENTS: The primary outcome was post-operative tumor proliferation measured by the mitotic activity index (MAI). The secondary outcomes were changes in the levels of serum insulin, insulin-c-peptide, glucose, IGF-1, and IGFBP3; patients' well-being, and clinical outcome over a median follow-up of 88 months (range 33-97 months).

RESULTS

In the estrogen receptor (ER) positive subgroup (n = 50), high proliferation (MAI ≥ 10) occurred more often in the carbohydrate group (CH) than in the fasting group (p = 0.038). The CH group was more frequently progesterone receptor (PR) negative (p = 0.014). The CH group had a significant increase in insulin (+ 24.31 mIE/L, 95% CI 15.34 mIE/L to 33.27 mIE/L) and insulin c-peptide (+ 1.39 nM, 95% CI 1.03 nM to 1.77 nM), but reduced IGFBP3 levels (- 0.26 nM; 95% CI - 0.46 nM to - 0.051 nM) compared to the fasting group. CH-intervention ER-positive patients had poorer relapse-free survival (73%) than the fasting group (100%; p = 0.012; HR = 9.3, 95% CI, 1.1 to 77.7). In the ER-positive patients, only tumor size (p = 0.021; HR = 6.07, 95% CI 1.31 to 28.03) and the CH/fasting subgrouping (p = 0.040; HR = 9.30, 95% CI 1.11 to 77.82) had independent prognostic value. The adverse clinical outcome of carbohydrate loading occurred only in T2 patients with relapse-free survival of 100% in the fasting group vs. 33% in the CH group (p = 0.015; HR = inf). The CH group reported less pain on days 5 and 6 than the control group (p <  0.001) but otherwise exhibited no factors related to well-being.

LIMITATION: Only applicable to T2 tumors in patients with ER-positive breast cancer.

CONCLUSIONS

Pre-operative carbohydrate load increases proliferation and PR-negativity in ER-positive patients and worsens clinical outcome in ER-positive T2 patients.

TRIAL REGISTRATION: CliniTrials.gov; NCT03886389. Retrospectively registered March 22, 2019.

Для цитирования: Lende Tone Hoel, Austdal Marie, Varhaugvik Anne Elin, Skaland Ivar, Gudlaugsson Einar, Kvaløy Jan Terje, Akslen Lars A, Søiland Håvard, Janssen Emiel A M, Baak Jan P A. Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial.. BMC cancer. 2019. DOI: 10.1186/s12885-019-6275-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.